Prediction-based prompt levothyroxine replacement to prevent a hypothyroid state after immune-related adverse events involving the thyroid gland-Reference-Cited by-同舟云学术

Prediction-based prompt levothyroxine replacement to prevent a hypothyroid state after immune-related adverse events involving the thyroid gland

Published:2023 Issue:10 Volume:70 Page:987-998
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Yamauchi Ichiro¹,Hakata Takuro¹,Sugawa Taku¹,Kosugi Daisuke¹,Fujita Haruka¹,Okamoto Kentaro¹,Ueda Yohei¹,Fujii Toshihito¹,Taura Daisuke¹,Harada Norio¹,Inagaki Nobuya²

Affiliation:

1. Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan

2. Medical Research Institute Kitano Hospital, PIIF Tazuke-kofukai, Osaka 530-8480, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/70/10/70_EJ23-0262/_pdf

Reference33 articles.

1. 1 Yamauchi I, Yasoda A, Matsumoto S, Sakamori Y, Kim YH, et al. (2019) Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab. PLoS One 14: e0216954.

2. 2 Kotwal A, Kottschade L, Ryder M (2020) PD-L1 inhibitor-induced thyroiditis is associated with better overall survival in cancer patients. Thyroid 30: 177–184.

3. 3 Basak EA, van der Meer JWM, Hurkmans DP, Schreurs MWJ, Oomen-de Hoop E, et al. (2020) Overt thyroid dysfunction and anti-thyroid antibodies predict response to anti-PD-1 immunotherapy in cancer patients. Thyroid 30: 966–973.

4. 4 Pollack R, Ashash A, Cahn A, Rottenberg Y, Stern H, et al. (2020) Immune checkpoint inhibitor-induced thyroid dysfunction is associated with higher body mass index. J Clin Endocrinol Metab 105: dgaa458.

5. 5 Muir CA, Clifton-Bligh RJ, Long GV, Scolyer RA, Lo SN, et al. (2021) Thyroid immune-related adverse events following immune checkpoint inhibitor treatment. J Clin Endocrinol Metab 106: e3704–e3713.